Home > industry-verticals > pharmaceuticals > > Pneumonia Therapeutics Market, Size, Share, Outlook and Growth Opportunities 2019-2026

Pneumonia Therapeutics Market, Size, Share, Outlook and Growth Opportunities 2019-2026

SKU: DPC278 | Last Updated On: Mar 02 2020 | No. of Pages: 246 | Available Formats

Request free sampleEnquire Before Purchase
> Global Pneumonia Therapeutics Market Expected to reach a high CAGR of 8.39% By 2026: DataM Intelligence

Pneumonia Therapeutics Market, Size, Share, Outlook and Growth Opportunities 2019-2026

SKU: DPC278 | Published On: Mar 02 2020 | No. of Pages: 246 | Available Formats

Global Pneumonia Therapeutics Market is segmented By Therapy (Prevention Vaccines, Treatment Drugs, Oxygen Therapy), By Distribution Channel (Hospitals, Pharmaceutical Stores, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2019-2026

 

Market Overview

The Global Pneumonia Therapeutics Market is expected to grow at a CAGR of 8.39% during the forecasting period (2019-2026).

Why Purchase the Report?

  • Visualize the composition of the Pneumonia Therapeutics Market across each product type and application highlighting the critical commercial assets and players.
  • Identify commercial opportunities in the Pneumonia Therapeutics Market by analyzing trends and co-development deals.
  • Comprehensive details on factors driving the market growth.
  • Excel data sheet with thousands of data points of Pneumonia Therapeutics Market segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Target Audience

  • Industry Investors/Investment Bankers
  • Suppliers/Buyers
  • Education & Research Institutes
  • Manufacturers
  • Research Professionals
  • Emerging Companies
  • Distributors

 

Table of Contents

1. Global Pneumonia Therapeutics Market Methodology and Scope

1.1. Research Methodology

1.2. Research Objective and Scope of the Report

2. Global Pneumonia Therapeutics Market – Market Definition and Overview

3. Global Pneumonia Therapeutics Market – Executive Summary

3.1. Market Snippet by Therapy

3.2. Market Snippet by Distribution Channel

3.3. Market Snippet by Region

3.4. DataM CLO Scenario

4. Global Pneumonia Therapeutics Market – Market Dynamics

4.1. Market Impacting Factors

4.1.1. Drivers

4.1.1.1. Increase in cases of pneumonia

4.1.1.2. Advancements in treatment

4.1.1.3. Increase in investment in research and development

4.1.1.4. Robust pipeline

4.1.2. Restraints

4.1.2.1. Development of antibiotic resistance

4.1.3. Opportunity

4.1.4. Impact Analysis

5. Global Pneumonia Therapeutics Market – Industry Analysis

5.1. Porter's Five Forces Analysis

5.2. Regulatory Analysis

5.3. Epidemiology

6. Global Pneumonia Therapeutics Market – Pipeline Analysis

7. Global Pneumonia Therapeutics Market – By Therapy

7.1. Introduction

7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By

Therapy

7.3. Market Attractiveness Index, By Therapy

7.4. Prevention Vaccines

7.4.1. Introduction

7.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)

7.4.3. Prevnar 13

7.4.4. Pneumovax 23

7.5. Treatment Drugs

7.5.1. Antibiotics

7.5.2. Antifungal

7.5.3. Antiviral

7.6. Oxygen Therapy

8. Global Pneumonia Therapeutics Market – By Distribution Channel

8.1. Introduction

8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By

Distribution Channel

8.3. Market Attractiveness Index, By Distribution Channel

8.4. Hospitals

8.4.1. Introduction

8.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)

8.5. Pharmaceutical Stores

8.6. Others

9. Global Pneumonia Therapeutics Market – By Region

9.1. Introduction

9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

9.3. Market Attractiveness Index, By Region

9.4. North America

9.4.1. Introduction

9.4.2. Key Region-Specific Dynamics

9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By

Therapy

9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By

Distribution Channel

9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By

Country

9.4.5.1. U.S.

9.4.5.2. Canada

9.4.5.3. Mexico

9.5. Europe

9.5.1. Introduction

9.5.2. Key Region-Specific Dynamics

9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By

Therapy

9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By

Distribution Channel

9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By

Country

9.5.5.1. Germany

9.5.5.2. U.K.

9.5.5.3. France

9.5.5.4. Italy

9.5.5.5. Spain

9.5.5.6. Rest of Europe

9.6. South America

9.6.1. Introduction

9.6.2. Key Region-Specific Dynamics

9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By

Therapy

9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By

Distribution Channel

9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By

Country

9.6.5.1. Brazil

9.6.5.2. Argentina

9.6.5.3. Rest of South America

9.7. Asia-Pacific

9.7.1. Introduction

9.7.2. Key Region-Specific Dynamics

9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By

Therapy

9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By

Distribution Channel

9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By

Country

9.7.5.1. China

9.7.5.2. India

9.7.5.3. Japan

9.7.5.4. Australia

9.7.5.5. Rest of Asia Pacific

9.8. Middle East and Africa

9.8.1. Introduction

9.8.2. Key Region-Specific Dynamics

9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By

Therapy

9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By

Distribution Channel

10. Global Market – Competitive Landscape

10.1. Competitive Scenario

10.2. Competitor Pneumonia Therapeutics Strategy Analysis

10.3. Comparative Product Portfolio Analysis

10.4. Market Positioning/Share Analysis

10.5. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Bayer AG *

11.1.1. Company Overview

11.1.2. Product Portfolio and Description

11.1.3. Key Highlights

11.1.4. Financial Overview

11.2. GlaxoSmithKline plc

11.3. Sanofi

11.4. Merck & Co. Inc.

11.5. Novartis AG

11.6. Eli Lilly and Company

11.7. AstraZeneca

11.8. Merck & Co.

11.9. Pfizer Inc.

11.10. Baxter International Inc.

11.11. Allergan

11.12. Lupin Pharmaceuticals Inc.

11.13. Biotest

11.14. Tetraphase Pharmaceuticals

12. Global Pneumonia Therapeutics Market – Premium Insights

13. Global Pneumonia Therapeutics Market – DataM

13.1. Appendix

13.2. About Us and Services

13.3. Contact Us

List of Tables and Figures

List of Tables

Table 1 Global Pneumonia Therapeutics Market Value, By Therapy, 2018,2022 & 2026 ($ Million)

Table 2 Global Pneumonia Therapeutics Market Value, By Distribution Channel, 2018,2022 & 2026 ($

Million)

Table 3 Global Pneumonia Therapeutics Market Value, By Region, 2018,2022 & 2026 ($ Million)

Table 4 Global Pneumonia Therapeutics Market Value, By Therapy, 2018,2022 & 2026 ($ Million)

Table 5 Global Pneumonia Therapeutics Market Value, By Therapy, 2017-2026 ($ Million)

Table 6 Global Pneumonia Therapeutics Market Value, By Distribution Channel, 2018,2022 & 2026 ($

Million)

Table 7 Global Pneumonia Therapeutics Market Value, By Distribution Channel, 2017-2026 ($ Million)

Table 8 Global Pneumonia Therapeutics Market Value, By Region, 2018,2022 & 2026 ($ Million)

Table 9 Global Pneumonia Therapeutics Market Value, By Region, 2017-2026 ($ Million)

Table 10 North America Pneumonia Therapeutics Market Value, By Therapy, 2017-2026 ($ Million)

Table 11 North America Pneumonia Therapeutics Market Value, By Distribution Channel, 2017-2026 ($

Million)

Table 12 North America Pneumonia Therapeutics Market Value, By Country, 2017-2026 ($ Million)

Table 13 South America Pneumonia Therapeutics Market Value, By Therapy, 2017-2026 ($ Million)

Table 14 South America Pneumonia Therapeutics Market Value, By Distribution Channel, 2017-2026 ($

Million)

Table 15 South America Pneumonia Therapeutics Market Value, By Country, 2017-2026 ($ Million)

Table 16 Europe Pneumonia Therapeutics Market Value, By Therapy, 2017-2026 ($ Million)

Table 17 Europe Pneumonia Therapeutics Market Value, By Distribution Channel, 2017-2026 ($

Million)

Table 18 Europe Pneumonia Therapeutics Market Value, By Country, 2017-2026 ($ Million)

Table 19 Asia-Pacific Pneumonia Therapeutics Market Value, By Therapy, 2017-2026 ($ Million)

Table 20 Asia-Pacific Pneumonia Therapeutics Market Value, By Distribution Channel, 2017-2026 ($

Million)

Table 21 Asia-Pacific Pneumonia Therapeutics Market Value, By Country, 2017-2026 ($ Million)

Table 22 Middle East & Africa Pneumonia Therapeutics Market Value, By Therapy, 2017-2026 ($

Million)

Table 23 Middle East & Africa Pneumonia Therapeutics Market Value, By Distribution Channel, 2017-

2026 ($ Million)

Table 24 Bayer AG: Overview

Table 25 Bayer AG: Product Portfolio

Table 26 Bayer AG: Key Developments

Table 27 GlaxoSmithKline plc: Overview

Table 28 GlaxoSmithKline plc: Product Portfolio

Table 29 GlaxoSmithKline plc: Key Developments

Table 30 Sanofi: Overview

Table 31 Sanofi: Product Portfolio

Table 32 Sanofi: Key Developments

Table 33 Merck & Co. Inc.: Overview

Table 34 Merck & Co. Inc.: Product Portfolio

Table 35 Merck & Co. Inc.: Key Developments

Table 36 Novartis AG: Overview

Table 37 Novartis AG: Product Portfolio

Table 38 Novartis AG: Key Developments

Table 39 Eli Lilly and Company: Overview

Table 40 Eli Lilly and Company: Product Portfolio

Table 41 Eli Lilly and Company: Key Developments

Table 42 AstraZeneca: Overview

Table 43 AstraZeneca: Product Portfolio

Table 44 AstraZeneca: Key Developments

Table 45 Merck & Co.: Overview

Table 46 Merck & Co.: Product Portfolio

Table 47 Merck & Co.: Key Developments

Table 48 Pfizer Inc.: Overview

Table 49 Pfizer Inc.: Product Portfolio

Table 50 Pfizer Inc.: Key Developments

Table 51 Baxter International Inc.: Overview

Table 52 Baxter International Inc.: Product Portfolio

Table 53 Baxter International Inc.: Key Developments

List of Figures

Figure 1 Global Pneumonia Therapeutics Market Share, By Therapy, 2018 & 2026 (%)

Figure 2 Global Pneumonia Therapeutics Market Share, By Distribution Channel, 2018 &

2026 (%)

Figure 3 Global Pneumonia Therapeutics Market Share, By Region, 2018 & 2026 (%)

Figure 4 Global Pneumonia Therapeutics Market Value, 2017-2026 ($ Million)

Figure 5 Global Pneumonia Therapeutics Market Y-o-Y Growth, By Therapy, 2018-2026 (%)

Figure 6 Prevention Vaccines: Global Pneumonia Therapeutics Market Value, 2017-2026

($ Million)

Figure 7 Treatment Drugs: Global Pneumonia Therapeutics Market Value, 2017-2026 ($

Million)

Figure 8 Oxygen Therapy: Global Pneumonia Therapeutics Market Value, 2017-2026 ($

Million)

Figure 9 Prevnar 13: Global Pneumonia Therapeutics Market Value, 2017-2026 ($ Million)

Figure 10 Pneumovax 23: Global Pneumonia Therapeutics Market Value, 2017-2026 ($

Million)

Figure 11 Antibiotics: Global Pneumonia Therapeutics Market Value, 2017-2026 ($ Million)

Figure 12 Antifungal: Global Pneumonia Therapeutics Market Value, 2017-2026 ($ Million)

Figure 13 Antiviral: Global Pneumonia Therapeutics Market Value, 2017-2026 ($ Million)

Figure 14 Global Pneumonia Therapeutics Market Y-o-Y Growth, By Distribution Channel,

2018-2026 (%)

Figure 15 Hospitals: Global Pneumonia Therapeutics Market Value, 2017-2026 ($ Million)

Figure 16 Pharmaceutical Stores: Global Pneumonia Therapeutics Market Value, 2017-2026

($ Million)

Figure 17 Others: Global Pneumonia Therapeutics Market Value, 2017-2026 ($ Million)

Figure 18 Global Pneumonia Therapeutics Market Y-o-Y Growth, By Region, 2018-2026 (%)

Figure 19 North America Pneumonia Therapeutics Market Value, 2017-2026 ($ Million)

Figure 20 North America Pneumonia Therapeutics Market Share, By Therapy, 2018 & 2026

(%)

Figure 21 North America Pneumonia Therapeutics Market Share, By Distribution Channel,

2018 & 2026 (%)

Figure 22 North America Pneumonia Therapeutics Market Share, By Country, 2018 & 2026

(%)

Figure 23 South America Pneumonia Therapeutics Market Value, 2017-2026 ($ Million)

Figure 24 South America Pneumonia Therapeutics Market Share, By Therapy, 2018 & 2026

(%)

Figure 25 South America Pneumonia Therapeutics Market Share, By Distribution Channel,

2018 & 2026 (%)

Figure 26 South America Pneumonia Therapeutics Market Share, By Country, 2018 & 2026

(%)

Figure 27 Europe Pneumonia Therapeutics Market Value, 2017-2026 ($ Million)

Figure 28 Europe Pneumonia Therapeutics Market Share, By Therapy, 2018 & 2026 (%)

Figure 29 Europe Pneumonia Therapeutics Market Share, By Distribution Channel, 2018 &

2026 (%)

Figure 30 Europe Pneumonia Therapeutics Market Share, By Country, 2018 & 2026 (%)

Figure 31 Asia-Pacific Pneumonia Therapeutics Market Value, 2017-2026 ($ Million)

Figure 32 Asia-Pacific Pneumonia Therapeutics Market Share, By Therapy, 2018 & 2026 (%)

Figure 33 Asia-Pacific Pneumonia Therapeutics Market Share, By Distribution Channel, 2018

& 2026 (%)

Figure 34 Asia-Pacific Pneumonia Therapeutics Market Share, By Country, 2018 & 2026 (%)

Figure 35 Middle East & Africa Pneumonia Therapeutics Market Value, 2017-2026 ($

Million)

Figure 36 Middle East & Africa Pneumonia Therapeutics Market Share, By Therapy, 2018 &

2026 (%)

Figure 37 Middle East & Africa Pneumonia Therapeutics Market Share, By Distribution

Channel, 2018 & 2026 (%)

Figure 38 Bayer AG: Financials

Figure 39 GlaxoSmithKline plc: Financials

Figure 40 Sanofi: Financials

Figure 41 Merck & Co. Inc.: Financials

Figure 42 Novartis AG: Financials

Figure 43 Eli Lilly and Company: Financials

Figure 44 AstraZeneca: Financials

Figure 45 Merck & Co.: Financials

Figure 46 Pfizer Inc.: Financials

Figure 47 Baxter International Inc.: Financials

 

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

Get your FREE SAMPLE PROPOSAL with a single click!

linkedinpinterest